Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.
Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
Conformational Landscape of N-Glycosylated Peptides Detecting Autoantibodies in Multiple Sclerosis, Revealed by Hamiltonian Replica Exchange.
Arzerra receives approval in Japan
Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
Expression and activation by epstein barr virus of human endogenous retroviruses-w in blood cells and astrocytes: inference for multiple sclerosis.
Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination.
A systematic review of research undertaken in vocational rehabilitation for people with multiple sclerosis.
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Cranial neuropathies in multiple sclerosis defined by magnetic resonance imaging and fludeoxyglucose f 18 positron emission tomography.
Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis.
[A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis].
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients (TERI-PRO)
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis.
Patients with migraine do not have MRI-visible cortical lesions.
Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease.
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.
Amyloid precursor protein at node of Ranvier modulates nodal formation.
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.

Pages